Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multi-site, Bayesian Platform Adaptive, Randomized, Placebo-controlled Trial Assessing the Effectiveness of Candidate Agents in Mitigating COVID-19 Disease in Adults

NCT04333732 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04333732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multi-site, Bayesian Platform Adaptive, Randomized, Placebo-controlled Trial Assessing the Effectiveness of Candidate Agents in Mitigating COVID-19 Disease in Adults
Lead sponsor
Washington University School of Medicine
Phase
Phase 3
Overall status
Completed
Start date
September 4, 2020
Completion date
December 3, 2021
Enrollment
3,411 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19